Avinger, Inc. (AVGR)
AVGRPrice: $0.47
Fair Value: 🔒
🔒score
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that i... more
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite o... more
Description
Shares
| Market Cap | $1.52M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Nabeel P. Subainati CPA |
| IPO Date | 2015-01-30 | CAGR | -0.01% |
| Employees | 68 | Website | avinger.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
AVGR chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.81M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.43 | P/B Ratio | 0.27 |
| P/CF Ratio | -0.16 | P/FCF Ratio | -0.24 |
| EPS | $-8.76 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -6.26% | Gross Margin | 0.23% |
| Operating Margin | -2.23% | Profit Margin | -2.31% |
| ROE | -1.39% | ROA | -0.59% |
| ROCE | -1.9% | Current Ratio | 1.21 |
| Quick Ratio | 0.81 | Cash Ratio | 0.62 |
| Debt/Equity | 1.44 | Interest Coverage | -33.32 |
| Altman Z Score | -48.28 | Piotroski Score | 4 |